CytomX Therapeutics
Latest round
- Series D
Last raised
- Jun 2015
Total raised
- $130M
Investors
- 13
About CytomX Therapeutics
Based in California, US, and founded in 2008, CytomX Therapeutics, Inc. is a biopharmaceutical firm focused on oncology that develops antibody medicines based on its pro-body technology platform to treat cancer.
Who invested in CytomX Therapeutics
13 investors across 5 rounds
See all investors in CytomX Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CytomX Therapeutics
Who invested in CytomX Therapeutics?
CytomX Therapeutics has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CytomX Therapeutics raised?
CytomX Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did CytomX Therapeutics last raise money?
CytomX Therapeutics's most recent round on record is a Series D, in Jun 2015.
What does CytomX Therapeutics do?
Based in California, US, and founded in 2008, CytomX Therapeutics, Inc.
Where is CytomX Therapeutics headquartered?
CytomX Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like CytomX Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CytomX Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like CytomX Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.